Invention Application
- Patent Title: Imidazopyridine Derivatives as Modulators of TNF Activity
- Patent Title (中): 咪唑并吡啶衍生物作为TNF活性的调节剂
-
Application No.: US15038555Application Date: 2014-12-08
-
Publication No.: US20160355509A1Publication Date: 2016-12-08
- Inventor: Victoria Elizabeth Jackson , Boris Kroeplien , John Robert Porter
- Applicant: UCB BIOPHARMA SPRL
- Priority: GB1321735.1 20131209
- International Application: PCT/EP2014/076837 WO 20141208
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/444 ; A61K31/437
Abstract:
A series of substituted 3H-imidazo[4,5-c]pyridine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
Public/Granted literature
- US09890154B2 Imidazopyridine derivatives as modulators of TNF activity Public/Granted day:2018-02-13
Information query
